Olima Ventures

What is Olima Ventures?

Olima Ventures is an investment fund founded by Vijay Pandurangan, who is also the founder of a biotech company, Ephla Bio, focusing on therapeutics targeting B-cell pathologies. Olima Ventures invests in a diverse range of sectors but shows particular interest in BioTech and A.I. (& Big Data), signaling a strong affinity for cutting-edge and impactful technologies. Their investment strategy encompasses the early stages of a company's growth, providing financial support in Seed, Pre-seed, and Series A rounds.

Olima Ventures' investment scale ranges from a minimum of $100,000 to a maximum of $5,000,000, with a sweet spot for investments around $1,500,000. This reflects a commitment to nurturing startups through critical development phases, paving the path from novel concepts to viable products and businesses.

Beyond financial investment, Vijay Pandurangan's background as a software engineer and manager at tech giants like Google and Twitter, as well as his experience with companies like Mitro and Benchmark Capital, provides an additional layer of expertise and mentorship to portfolio companies.

Vijay's interests in applying machine learning and computational techniques to therapeutics and improving the quality of software engineering in sciences further underline Olima Ventures' dedication to advancing technology and science. The fund is sector-agnostic but possesses a strong technological and scientific undercurrent, hinting at their desire to invest in startups that are positioned to drive significant advancements in their respective fields.

What they say:

We invest early in great teams creating a frictionless future—primarily in biotech, B2B, distributed systems, and enterprise software.